Acadian Asset Management LLC Concert Pharmaceuticals, Inc. Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.34 - $5.84 $537,469 - $723,231	123,841 Added 19.68%	753,140 $4.4 Million
Q3 2022 Nov 14, 2022	SELL	$4.27 - $7.2 $913,891 - $1.54 Million	-214,026 Reduced 25.38%	629,299 $4.21 Million
Q2 2022 Aug 09, 2022	BUY	$2.8 - $6.36 $137,813 - $313,032	49,219 Added 6.2%	843,325 $3.55 Million
Q1 2022 May 12, 2022	BUY	$2.73 - $3.94 $30,829 - $44,494	11,293 Added 1.44%	794,106 $2.68 Million
Q4 2021 Feb 10, 2022	BUY	$2.69 - $4.22 $221,852 - $348,036	82,473 Added 11.78%	782,813 $2.47 Million
Q3 2021 Nov 12, 2021	BUY	$3.17 - $4.15 $277,783 - $363,660	87,629 Added 14.3%	700,340 $2.29 Million
Q2 2021 Aug 11, 2021	BUY	$3.77 - $5.24 $298,350 - $414,683	79,138 Added 14.83%	612,711 $2.59 Million
Q1 2021 May 11, 2021	BUY	$4.86 - $13.07 $2.09 Million - $5.62 Million	430,297 Added 416.65%	533,573 $2.66 Million
Q4 2020 Feb 11, 2021	SELL	$9.48 - $12.84 $84,457 - $114,391	-8,909 Reduced 7.94%	103,276 $1.31 Million
Q3 2020 Nov 09, 2020	SELL	$8.67 - $10.82 $408,729 - $510,087	-47,143 Reduced 29.59%	112,185 $1.1 Million
Q2 2020 Aug 12, 2020	SELL	$7.8 - $11.52 $200,709 - $296,432	-25,732 Reduced 13.9%	159,328 $1.59 Million
Q1 2020 May 11, 2020	SELL	$5.98 - $13.09 $275,725 - $603,553	-46,108 Reduced 19.95%	185,060 $1.64 Million
Q4 2019 Feb 06, 2020	SELL	$5.71 - $9.22 $198,142 - $319,943	-34,701 Reduced 13.05%	231,168 $2.13 Million
Q3 2019 Nov 07, 2019	SELL	$5.88 - $12.35 $440,018 - $924,187	-74,833 Reduced 21.96%	265,869 $1.57 Million
Q2 2019 Aug 08, 2019	SELL	$9.44 - $13.12 $1.84 Million - $2.55 Million	-194,471 Reduced 36.34%	340,702 $4.09 Million
Q1 2019 May 09, 2019	SELL	$12.07 - $17.54 $1.46 Million - $2.13 Million	-121,331 Reduced 18.48%	535,173 $6.46 Million
Q4 2018 Feb 07, 2019	SELL	$11.25 - $16.17 $3.07 Million - $4.42 Million	-273,268 Reduced 29.39%	656,504 $8.24 Million
Q3 2018 Oct 30, 2018	SELL	$12.82 - $17.88 $147,558 - $205,798	-11,510 Reduced 1.22%	929,772 $13.8 Million
Q2 2018 Jul 24, 2018	BUY	$16.83 - $21.66 $1.61 Million - $2.08 Million	95,863 Added 11.34%	941,282 $15.8 Million
Q1 2018 Apr 12, 2018	BUY	$19.24 - $28.03 $10.5 Million - $15.3 Million	547,383 Added 183.66%	845,419 $19.4 Million
Q4 2017 Jan 18, 2018	BUY	$13.96 - $29.05 $4.16 Million - $8.66 Million	298,036	298,036 $7.71 Million

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account